bpc-157 not approved by fda statement BPC-157's Review Raises Questions About Its Origins | American Peptide Society posted on the topic FDA Puts BPC-157, TB-500, and
Description
Storage & Handling Lyophilized AOD-9604 (Research Workflow)

Note the number: this is a weak dose for weight but the proven dose for the kidney, and the benefit belongs to that specific population

Had no reaction UNTIL the night of 2/8/2/9
Beneficial for heart, liver and kidney metabolic support

Inhibitors that prevent activin receptor IIB activation and myostatin-binding proteins (e.g., follistatin) fall under WADA's expanded interpretation
They begin to suffer from anemia, nerve damage, and other problems
